Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Lohrmann

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Cardiovascular Electrophysiology|December 21, 2020
The future of long-term monitoring following catheter and surgical intervention for atrial fibrillationGraham Lohrmann, Rod Passman
Cardiology in Review|July 29, 2024
Controversies in Diagnosis and Management of Atrial FibrillationTanvi Nayak, Graham Lohrmann, Rod Passman
Journal of Cardiovascular Electrophysiology|June 19, 2024
KardiaMobile 6L versus 12-lead ECG: Effects on clinic utilization timeMeghna Gaddam, Albert Liu, Graham Lohrmann, et al.
Journal of Cardiovascular Electrophysiology|October 20, 2020
Atrial fibrillation ablation success defined by duration of recurrence on cardiac implantable electronic devicesGraham Lohrmann, Rachel Kaplan, Paul D Ziegler, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|August 2, 2022
CHA<sub>2</sub>DS<sub>2</sub>VASc score as a predictor of ablation success defined by continuous long-term monitoringGraham Lohrmann, Albert Liu, Paul Ziegler, et al.
JACC. Cardiooncology|January 29, 2021
Left Atrial Mechanics Associates With Paroxysmal Atrial Fibrillation in Light-Chain Amyloidosis Following Stem Cell TransplantationGraham Lohrmann, Monica Arun Patel, Dina Brauneis, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 27, 2022
Diflunisal treatment is associated with improved survival for patients with early stage wild-type transthyretin (ATTR) amyloid cardiomyopathy: the Boston University Amyloidosis Center experienceOmar K Siddiqi, Yuliya Y Mints, John L Berk, et al.
Journal of Cardiac Failure|December 6, 2019
Stabilization of Cardiac Function With Diflunisal in Transthyretin (ATTR) Cardiac AmyloidosisGraham Lohrmann, Alexandra Pipilas, Roberta Mussinelli, et al.
Journal of Cardiovascular Electrophysiology|January 14, 2023
Implementation of an intravenous sotalol initiation protocol: Implications for feasibility, safety, and length of stayAlbert Y Liu, Jessica Charron, Dana Fugaro, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|May 18, 2024
Safety and feasibility of intravenous sotalol loading for the prevention of ventricular arrhythmiasAbhinav Sehgal, Arati Gangadharan, Herman A Carneiro, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Cardiovascular Electrophysiology|December 21, 2020
The future of long-term monitoring following catheter and surgical intervention for atrial fibrillationGraham Lohrmann, Rod Passman
Cardiology in Review|July 29, 2024
Controversies in Diagnosis and Management of Atrial FibrillationTanvi Nayak, Graham Lohrmann, Rod Passman
Journal of Cardiovascular Electrophysiology|June 19, 2024
KardiaMobile 6L versus 12-lead ECG: Effects on clinic utilization timeMeghna Gaddam, Albert Liu, Graham Lohrmann, et al.
Journal of Cardiovascular Electrophysiology|October 20, 2020
Atrial fibrillation ablation success defined by duration of recurrence on cardiac implantable electronic devicesGraham Lohrmann, Rachel Kaplan, Paul D Ziegler, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|August 2, 2022
CHA<sub>2</sub>DS<sub>2</sub>VASc score as a predictor of ablation success defined by continuous long-term monitoringGraham Lohrmann, Albert Liu, Paul Ziegler, et al.
JACC. Cardiooncology|January 29, 2021
Left Atrial Mechanics Associates With Paroxysmal Atrial Fibrillation in Light-Chain Amyloidosis Following Stem Cell TransplantationGraham Lohrmann, Monica Arun Patel, Dina Brauneis, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 27, 2022
Diflunisal treatment is associated with improved survival for patients with early stage wild-type transthyretin (ATTR) amyloid cardiomyopathy: the Boston University Amyloidosis Center experienceOmar K Siddiqi, Yuliya Y Mints, John L Berk, et al.
Journal of Cardiac Failure|December 6, 2019
Stabilization of Cardiac Function With Diflunisal in Transthyretin (ATTR) Cardiac AmyloidosisGraham Lohrmann, Alexandra Pipilas, Roberta Mussinelli, et al.
Journal of Cardiovascular Electrophysiology|January 14, 2023
Implementation of an intravenous sotalol initiation protocol: Implications for feasibility, safety, and length of stayAlbert Y Liu, Jessica Charron, Dana Fugaro, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|May 18, 2024
Safety and feasibility of intravenous sotalol loading for the prevention of ventricular arrhythmiasAbhinav Sehgal, Arati Gangadharan, Herman A Carneiro, et al.
Pageof 2